Lixte Biotechnology raises $1.05M in registered direct offering and private placement

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Issued 434,784 shares at $2.415/share and warrants for 434,784 shares at $2.29/share.
Warrants are immediately exercisable for a five-year term; gross proceeds ~$1.05M.
Offering closed on Feb 13, 2025; net proceeds for working capital and general corporate purposes.
H.C. Wainwright acted as exclusive placement agent with 7.5% cash fee and warrants.
Private placement warrants and underlying shares unregistered, resale registration to be filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.